Discover how haptoglobin and glutamine synthetase serve as potential biomarkers for chemotherapy-induced cachexia in acute myeloid leukemia patients.
Discover how AS1411, a revolutionary DNA aptamer, targets leukemia stem cells in AML treatment with unprecedented precision.